Related Experiment Video
Updated: Feb 5, 2026

Development of Heterogeneous Enantioselective Catalysts using Chiral Metal-Organic Frameworks MOFs
Published on: January 17, 2020
Overcoming Site Heterogeneity In Search of Metal Nanocatalysts
Siwen Wang1, Noushin Omidvar1, Emily Marx1
1Department of Chemical Engineering , Virginia Polytechnic Institute and State University , Blacksburg , Virginia 24061 , United States.
Abstract:
Site heterogeneity of metal nanocatalysts poses grand challenges for catalyst design from first principles. To accelerate catalyst discovery, it is of pivotal importance to develop an approach that efficiently maps catalytic activity of nanoparticles onto geometry-based descriptors while considering the geometric strain and metal ligand of an active site. We demonstrate that there exist linear correlations between orbitalwise coordination numbers CNα and free formation energies of oxygen species (e.g., *OH and *OOH) at Pt sites. Kinetic analysis along with herein developed structure-activity relationships accurately predicts the activity trend of pure Pt nanoparticles (∼1-7 nm) toward oxygen reduction. Application of the approach to a search of Pt nanoalloys leads to several Pt monolayer core-shell nanostructures with enhanced oxygen reduction activity and reduced cost. The approach presented here facilitates a transition from traditional single-crystal models to nanoparticles in theory-guided catalyst discovery.
Related Concept Videos
Bonding in Metals
Metallic Solids
All metallic solids exhibit high thermal and electrical conductivity, metallic luster, and malleability....
Alkali Metals
Table 1: Properties of the alkali metals
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Properties of Transition Metals
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

